Divergent regulation of proteasomes by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone

Growth Hormone and IGF Research

Volumn 12, Issue 6, 2002, Pages 434-441

  Chrysis, Dionisios ^a   Zhang, Jihui ^b   Underwood, Louis E ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Catabolism; Dexamethasone; GH; IGF I; Proteasome; Ubiquitin

Indexed keywords

DEXAMETHASONE; GROWTH HORMONE; MESSENGER RNA; MUSCLE PROTEIN; PROTEASOME; SOMATOMEDIN C; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME; 26S PROTEASOME NON ATPASE REGULATORY SUBUNIT 13; 26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 13; ADENOSINE TRIPHOSPHATASE; ATP DEPENDENT 26S PROTEASE; CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; PEPTIDE HYDROLASE; PROTEIN SUBUNIT; PROTEINASE;

ANIMAL MODEL; ANIMAL TISSUE; CATABOLISM; CONTROLLED STUDY; DOWN REGULATION; ENZYME SUBUNIT; HORMONE ACTION; LIVER; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; REVIEW; RNA TRANSCRIPTION; SKELETAL MUSCLE; UPREGULATION; ANIMAL; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; GENETICS; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CYSTEINE ENDOPEPTIDASES; DEXAMETHASONE; DOWN-REGULATION; ENDOPEPTIDASES; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MALE; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UBIQUITIN;

EID: 0036893591     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(02)00116-8     Document Type: Article

References (53)

1. Auclair D, Garrel DR, Zerouala AC, Ferland LH. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am J Physiol 1997; 272: C1007-C016.
2. Dardevet D, Sornet C, Taillandier D, Savary I, Attaix D, Grizard J. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscles from adult and old rats. J Clin Invest 1995; 95: 2113-2119.
3. Mitch WE, Medina R, Greiber S, May RC, England BK, Price SR, Bailey JL, Goldberg AL. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 1994; 93: 2127-2133.
4. Wing SS, Haas AL, Goldberg AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation. Biochem J 1995; 307: 639-645.
5. Medina R, Wing SS, Goldberg AL. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 1995; 307: 631-637.
6. Baracos VE, DeVivo C, Hoyle DHR, Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing hepatome. Am J Physiol 1995; 268: E996-E1006.
7. Fang CH, Tiao G, James JH, Ogle C, Fischer JE, Hasselgren PO. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J Am Coll Surg 1995; 180: 161-170.
8. Price SR, Bailey JL, Wang X, Jurkovitz C, England BK, Ding X, Philips LS, Mitch WE. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 1996; 98: 1703-1708.
9. Chrysis D, Underwood LE. Regulation of components of the ubiquitin system by Insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Endocrinology 1999; 140: 5635-5641.
10. Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitin- dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 1993; 264: E668-E676.
11. May RC, Kelly RA, Mitch WE. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 1986; 77: 614-621.
12. Hall-Angeras M, Angeras U, Zamir O, Hasselgren PO, Fischer JE. Effect of the glucocorticoid receptor antagonist RU 38486 on muscle protein breakdown in sepsis. Surgery 1991; 109: 468-473.
13. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990; 86: 265-272.
14. Oehri M, Ninnis R, Girard J, Frey FJ, Keller U. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans. Am J Physiol 1996; 270: E552-E558.
15. Snyder DK, Clemmons DR, Underwood LE. Treatment of obese, diet- restricted subjects with growth hormone for 11 weeks: effects of anabolism, lipolysis and body composition. J Clin Endocrinol Metab 1988; 67: 54-61.
16. Clemmons DR, Smith-Banks A, Underwood LE. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab 1992; 75: 234-238.
17. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-I by use both agents simultaneously. J Clin Invest 1993; 91: 391-396.
18. Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RS. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. J Clin Invest 1989; 83: 1717-1723.
19. Tomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, Read LC, Ballard FJ. Insulin-like growth factor I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem J 1992; 282: 91-97.
20. Yang H, Grahn M, Schalch DS, Ney DM. Anabolic effects of IGF-I coinfused with total parenteral nutrition in dexamethasone-treated rats. Am J Physiol 1994; 266: E690-E698.
21. Ballard FJ, Read LC, Francis GL, Bagley CJ, Wallace JC. Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts. Biochem J 1986; 233: 223-230.
22. Fang CH, Li BG, Wang JJ, Fischer JE, Hasselgren PO. Insulin-like growth factor-I stimulated protein synthesis and inhibits protein breakdown in muscle from burned rats. J Parenteral Enteral Nutr 1997; 21: 245-251.
23. Fujiwara T, Tanaka K, Kumatori A, Shin S, Yoshimura T, Ichihara A, Tokunaga F, Aruga R, Iwanaga S, Kakizuka A, Nakanishi S. Molecular cloning of cDNA for proteasomes (multicatalytic proteinase complexes) from rat liver: Primer structure of the largest cocmonent (C2). Biochemistry 1989; 28: 7332-7340.
24. Tanaka K, Fujiwara T, Kumatori A, Shin S, Yoshimura T, Ichihara A, Tokunaga F, Aruga R, Iwanaga S, Kakizuka A, Nakanishi S. Molecular cloning of cDNA for proteasomes from rat liver: primary structure of component C3 with possible tyrosine phosphorylation site. Biochemistry 1990; 29: 3777-3785.
25. Tamura T, Tanaka K, Kumatori A, Yamada F, Tsurumi C, Fujiwara T, Ichihara A, Tokunaga F, Aruga R, Iwanaga S. cDNA cloning and sequencing of component C5 of proteasomes from rat hepatoma cells. FEBS Lett 1990; 264: 91-94.
26. Ni R, Tomita Y, Tokunaga F, Liang TJ, Noda C, Ichihara A, Tanaka K. Molecular cloning of two types of cDNA encoding subunit RC6-I of rat proteasomes. Biochim Biophys Acta 1995; 1264: 45-52.
27. Tanaka K, Kanayama H, Tamura T, Lee DH, Kumatori A, Fujiwara T, Ichihara A, Tokunaga F, Aruga R, Iwanaga S. cDNA cloning and sequencing of component C8 of proteasomes from rat hepatoma cells. Biochem Biophys Res Commun 1990; 171: 676-683.
28. Kumatori A, Tanaka K, Tamura T, Fujiwara T, Ichihara A, Tokunaga F, Onikura A, Iwanaga S. cDNA cloning and sequencing of component C9 of proteasomes from rat hepatoma cells. FEBS Lett 1990; 264: 279-282.
29. Chrysis D, Moats-Staats BM, Underwood LE. Effects of fasting on insulin receptor-related receptor messanger ribonucleic acid in rat kidney. J Endocrinol 1998; 159: R9-R12.
30. Davenport ML, Svoboda ME, Koerber KL, Van Wyk JJ, Clemmons DR, Underwood LE. Serum concentrations of insulin-like growth factor II are not changed by short-term fasting and refeeding. J Clin Endocrinol Metab 1988; 67: 1231-1236.
31. Bowes SB, Jackson NC, Papachristodoulou D, Umpleby AM, Sonksen PH. Effect of corticosterone on protein degradation in isolated rat soleus and extensor digitorum longus muscles. J Endocrinol 1996; 148: 501-507.
32. Odera BR, Bates PC, Millward DJ. Time course of the effect of catabolic doses of corticosterone on protein turnover in rat skeletal muscle and liver. Biochem J 1983; 214: 617-627.
33. Konagay M, Bernard PA, Max SR. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. Endocrinology 1986; 119: 375-380.
34. M. Rechsteiner, The 26S proteasome, in: Peters J-M, Harris JR, Finley, D, eds, Ubiquitin and the Biology of the Cell. New York: Plenum publishing 1998: 147-189.
35. Tanaka K, Tamura T, Tanahashi N, Tsurumi C. Protein and gene structure of 20S and 26S proteasomes. Adv Exp Med Biol 1996; 389: 187-194.
36. Du J, Mitch WE, Wang X, Price SR. Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-κB. J Biol Chem 2000; 275: 19661-19666.
37. Luo G, Sun X, Hungness E, Hasselgren PO. Heat shock protects L6 myotubes from catabolic effects of dexamethasone and prevents downregulation of NF-κB. Am J Physiol Regulatory Integrative Comp Physiol 2001; 281: R1193-R1200.
38. Jeschke MG, Herndon DN, Vita R, Traber DL, Jauch KW, Barrow RE. IGF-I/BP-3 administration preserves hepatic homeostasis after thermal injury which is associated with increases in NO and hepatic NF-κB. Shock 2001; 16: 373-379.
39. Liu W, Liu Y, Lowe WL Jr. The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-I-mediated effects in vascural endothelial cells. Endocrinology 2001; 142: 1710-1719.
40. Pons S, Torres-Aleman I. Insulin-like growth factor-I stimulates dephosphorylation of iκ B through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem 2000; 275: 38620-38625.
41. Heck S, Lezoualc'h F, Engert S, Behl C. Insulin like growth factor-I-mediated neuroprotection against oxidative stress is associated with activation of neuronal factor κB. J Biol Chem 1999; 274: 9828-9835.
42. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 17: 481-517.
43. Wing SS, Bedard N. Insulin-like growth factor I stimulates degradation of an mRNA transcript encoding the 14-kDa ubiquitin-conjugating enzyme. Biochem J 1996; 319: 455-461.
44. Roupas P, Herington A. Intracellular processing of growth hormone receptors by adipocytes in primary culture. Mol Cell Endocrinol 1988; 57: 93-99.
45. Argetsinger LS, Carter SC. Mechanism of signaling by growth hormone receptor. Physiol Rev 1996; 76: 1089-1107.
46. Gorin E, Goodman HM. Turnover of growth hormone receptors in rat adipocytes. Endocrinology 1985; 116: 1796-1805.
47. Hackett RH, Wang YD, Sweitzer S, Feldman G, Wood WI, Larner AC. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins. J Biol Chem 1997; 272: 11128-11132.
48. Strous GJ, van Kerkhof P, Govers R, Ciechanover A, Schwartz A. The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J 1996; 15: 3806-3812.
49. van Kerkhof P, Govers R, Alves dos Santos CM, Strous GJ. Endocytosis and degradation of the growth hormone receptor are proteasome-dependent. J Biol Chem 2000; 275: 1575-1580.
50. Strous GJ, van Kerkhof P, Govers R, Rotwein P, Schwartz AL. Growth hormone-induced signal transduction depends on an intact ubiquitin system. J Biol Chem 1997; 272: 40-43.
51. Alves dos Santos CM, van Kerkhof P, Strous GJ. The signal transduction of the growth hormone receptor is regulated by the ubiquitin/proteasome system and continues after endocytosis. J Biol Chem 2001; 276: 10839-10846.
52. Tollet-Egnell P, Flores-Morales A, Stavreus-Evers A, Shalin L, Norstedt G. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 1999; 140: 3693-3704.
53. Ram PA, Waxman DJ. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 1999; 274: 35553-35561.